Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
MONARCC: a randomised phase II study of panitumumab monotherapy and panitumumab plus 5-fluorouracil as first-line therapy for RAS and BRAF wildtype metastatic colorectal cancer: a study by the Australasian Gastrointestinal Trials Group (AGITG).
Siu HWD, Tebbutt N, Chantrill L, Karapetis C, Steer C, Wilson K, Espinoza D, Bailey L, Yip S, Cuff J, Pavlakis N, Thavaneswaran S, Briscoe K, Srivastav R, Shannon J, Segelov E, Tie J, Caird S, Francesconi A, Price T, Wuttke M, Ladwa R, Sjoquist K, Burge M. Siu HWD, et al. Among authors: ladwa r. BMC Cancer. 2021 Aug 18;21(1):932. doi: 10.1186/s12885-021-08644-4. BMC Cancer. 2021. PMID: 34407800 Free PMC article.
How frail is frail in oncology studies? A scoping review.
Fletcher JA, Logan B, Reid N, Gordon EH, Ladwa R, Hubbard RE. Fletcher JA, et al. Among authors: ladwa r. BMC Cancer. 2023 Jun 2;23(1):498. doi: 10.1186/s12885-023-10933-z. BMC Cancer. 2023. PMID: 37268891 Free PMC article. Review.
Immune checkpoint inhibitors in advanced nasopharyngeal carcinoma: Beyond an era of chemoradiation?
Masterson L, Howard J, Gonzalez-Cruz J, Jackson C, Barnett C, Overton L, Liu H, Ladwa R, Simpson F, McGrath M, Wallwork B, Jones T, Ottensmeier C, Chua MLK, Perry C, Khanna R, Panizza B, Porceddu S, Lechner M. Masterson L, et al. Among authors: ladwa r. Int J Cancer. 2020 Apr 15;146(8):2305-2314. doi: 10.1002/ijc.32869. Epub 2020 Jan 28. Int J Cancer. 2020. PMID: 31950498 Review.
Analysis of human leukocyte antigen associations in human papillomavirus-positive and -negative head and neck cancer: Comparison with cervical cancer.
Ekanayake Weeramange C, Shu D, Tang KD, Batra J, Ladwa R, Kenny L, Vasani S, Frazer IH, Dolcetti R, Ellis JJ, Sturm RA, Leo P, Punyadeera C. Ekanayake Weeramange C, et al. Among authors: ladwa r. Cancer. 2022 May 15;128(10):1937-1947. doi: 10.1002/cncr.34148. Epub 2022 Feb 17. Cancer. 2022. PMID: 35176174 Free PMC article.
A phase 1, single centre, open label, escalating dose study to assess the safety, tolerability and immunogenicity of a therapeutic human papillomavirus (HPV) DNA vaccine (AMV002) for HPV-associated head and neck cancer (HNC).
Chandra J, Woo WP, Finlayson N, Liu HY, McGrath M, Ladwa R, Brauer M, Xu Y, Hanson S, Panizza B, Frazer IH, Porceddu SV. Chandra J, et al. Among authors: ladwa r. Cancer Immunol Immunother. 2021 Mar;70(3):743-753. doi: 10.1007/s00262-020-02720-7. Epub 2020 Sep 12. Cancer Immunol Immunother. 2021. PMID: 32918586 Free PMC article. Clinical Trial.
73 results